Page last updated: 2024-11-05

zolpidem and Alogia

zolpidem has been researched along with Alogia in 2 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research Excerpts

ExcerptRelevanceReference
"Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents."4.84Pharmacotherapy of aphasia: myth or reality? ( de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, L1
Chaaban, B1
Habert, MO1
de Boissezon, X1
Peran, P1
de Boysson, C1
Démonet, JF1

Reviews

1 review available for zolpidem and Alogia

ArticleYear
Pharmacotherapy of aphasia: myth or reality?
    Brain and language, 2007, Volume: 102, Issue:1

    Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil;

2007

Other Studies

1 other study available for zolpidem and Alogia

ArticleYear
Transient improvement of aphasia with zolpidem.
    The New England journal of medicine, 2004, Feb-26, Volume: 350, Issue:9

    Topics: Aphasia; Cerebrovascular Circulation; Female; GABA Agonists; Humans; Middle Aged; Pyridines; Stroke;

2004